Heart Disease Trial, Recruiting NCT06844032 Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06844032
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have signed and dated a consent form agreeing to take part in the study
  • You have been diagnosed with heart failure that causes symptoms during moderate or minimal physical activity (classified as NYHA class II or III)
  • Your heart's pumping function is relatively preserved, meaning your heart pumps out more than 50% of its blood with each beat
  • Tests (ultrasound of the heart) show that pressure inside your heart is higher than normal, either at rest or during exercise

Who may not be able to join:

  • Tests show that your heart muscle is not getting enough blood during exercise (signs of ischemia on a stress test)
  • You have significant blockages in your main heart arteries
  • Your heart failure is caused by a genetic condition, such as hypertrophic cardiomyopathy, amyloidosis, Fabry disease, or similar inherited disorders
  • Your heart failure is related to pregnancy, chemotherapy, a viral heart infection, certain conditions affecting only the right side of the heart, or conditions affecting the sac around the heart
  • You have severe lung disease that requires you to use oxygen at home or take steroid tablets regularly
  • You have high blood pressure in the arteries of your lungs that is not caused by another heart or lung condition
  • You have significant disease affecting the valves on the left side of your heart
  • You have anaemia (low red blood cell levels, specifically haemoglobin below 100 g/L)
  • Your kidneys are not working well enough (kidney function below a certain level, confirmed by a blood test — confirm with trial site)
  • You have another serious non-heart-related health condition that would make taking part difficult or unsafe (confirm with trial site)
  • You had a worsening episode of heart failure within the last 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Registry
ClinicalTrials.gov
Start date
31 January 2022
Est. completion
31 December 2026

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Hospitalization for exacerbation of HF; All-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov